BOOST Pharma has appointed Hans Schambye as its new chief [...]
SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]
BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]
Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]
NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]
Kahimmune Therapeutics signs exclusive licensing agreement with Gustave Roussy and SATT Paris-Saclay
Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]
A new survey by Sapio Sciences has found widespread frustration [...]
TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]
Evestia Clinical has acquired Berlin-based CRO and scientific consultancy ICRC-Weyer [...]
MaaT Pharma has reported its half year 2025 financial results, [...]